MedTrace Logo

Comparison of Intravenous Co-amoxiclav Versus Benzyl Penicillin

NCT04215770 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 310

Last updated 2020-01-03

No results posted yet for this study

Summary

To compare intravenous Co-amoxiclav versus Benzyl penicillin in children with severe streptococcal tonsillitis in terms of efficacy, safety and cost effectiveness.

Conditions

  • Tonsillitis Streptococcal

Interventions

DRUG

inj co-amoxiclav 50 units/kg/day vs inj Benzyl Penicillin 25000 units/kg/day

Patients of both groups were examined and compared in terms of efficacy of treatment, safety and cost effectiveness

Sponsors & Collaborators

  • Combined Military Hospital, Pakistan

    lead OTHER

Principal Investigators

  • Ahmed Khan, MBBS, FCPS · CMH Mardan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-11-01
Completion
2019-11-01

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04215770 on ClinicalTrials.gov